MAA
TRIB

Managed Account Advisors’s Trinity Biotech TRIB Stock Holding History

Managed Account Advisors’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-4
Closed – – 2786
2014
Q3 		$0 Sell
4
-144
-97% -$15.6K ﹤0.01% 2723
2014
Q2 		$17K Hold
148
– – ﹤0.01% 2530
2014
Q1 		$18K Buy
+148
New +$19.4K ﹤0.01% 2485

Other funds holding TRIB

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Managed Account Advisors's TRIB Position: Q4 2014 in Review

Managed Account Advisors sold out of Trinity Biotech (TRIB) in Q4 2014, closing a stake of 4 shares.

Managed Account Advisors first reported a position in TRIB in Q1 2014 and held it in 3 quarters. The position peaked at $18K in Q1 2014. 92 funds tracked by Wall St. Rank hold TRIB as of Q4 2014.

  • Managed Account Advisors reported no remaining Trinity Biotech position as of Q4 2014 after selling out during the quarter.
  • Managed Account Advisors sold 4 Trinity Biotech shares in Q4 2014.
  • Managed Account Advisors first reported a position in Trinity Biotech in Q1 2014 and held it in 3 quarters.
  • Managed Account Advisors's Trinity Biotech position peaked at $18K in Q1 2014.
  • 92 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2014.

Based on Managed Account Advisors's 13F filing for Q4 2014, filed 13 Feb 2015.